These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 32377541)

  • 1. Emerging Prospects for Nanoparticle-Enabled Cancer Immunotherapy.
    Buabeid MA; Arafa EA; Murtaza G
    J Immunol Res; 2020; 2020():9624532. PubMed ID: 32377541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
    Liu J; Zhang R; Xu ZP
    Small; 2019 Aug; 15(32):e1900262. PubMed ID: 30908864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering Nanoparticles to Reprogram the Tumor Immune Microenvironment for Improved Cancer Immunotherapy.
    Saeed M; Gao J; Shi Y; Lammers T; Yu H
    Theranostics; 2019; 9(26):7981-8000. PubMed ID: 31754376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-Based Phototriggered Cancer Immunotherapy and Its Domino Effect in the Tumor Microenvironment.
    Rajendrakumar SK; Uthaman S; Cho CS; Park IK
    Biomacromolecules; 2018 Jun; 19(6):1869-1887. PubMed ID: 29677439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles.
    Zhang M; Kim JA; Huang AY
    Front Immunol; 2018; 9():341. PubMed ID: 29535722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles for tumor immunotherapy.
    Zang X; Zhao X; Hu H; Qiao M; Deng Y; Chen D
    Eur J Pharm Biopharm; 2017 Jun; 115():243-256. PubMed ID: 28323111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
    Grimaldi AM; Incoronato M; Salvatore M; Soricelli A
    Nanomedicine (Lond); 2017 Oct; 12(19):2349-2365. PubMed ID: 28868980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.
    Li S; Bennett ZT; Sumer BD; Gao J
    Acc Chem Res; 2020 Nov; 53(11):2546-2557. PubMed ID: 33063517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticulate immunotherapy for cancer.
    Kapadia CH; Perry JL; Tian S; Luft JC; DeSimone JM
    J Control Release; 2015 Dec; 219():167-180. PubMed ID: 26432555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined strategies for tumor immunotherapy with nanoparticles.
    Savitsky K; Yu X
    Clin Transl Oncol; 2019 Nov; 21(11):1441-1449. PubMed ID: 31055713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential applications of nanoparticles for tumor microenvironment remodeling to ameliorate cancer immunotherapy.
    Bai Y; Wang Y; Zhang X; Fu J; Xing X; Wang C; Gao L; Liu Y; Shi L
    Int J Pharm; 2019 Oct; 570():118636. PubMed ID: 31446027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree.
    Sheen MR; Fiering S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1524. PubMed ID: 29667346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of nanoparticle vaccines as a treatment for cancer.
    Urbanavicius D; Alvarez T; Such GK; Johnston APR; Mintern JD
    Mol Immunol; 2018 Jun; 98():2-7. PubMed ID: 29395251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial immunotherapy and nanoparticle mediated hyperthermia.
    Moy AJ; Tunnell JW
    Adv Drug Deliv Rev; 2017 May; 114():175-183. PubMed ID: 28625829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy.
    Xing H; Li X
    Chemistry; 2024 Jun; 30(32):e202400425. PubMed ID: 38576219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy.
    Musetti S; Huang L
    ACS Nano; 2018 Dec; 12(12):11740-11755. PubMed ID: 30508378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New opportunities for nanoparticles in cancer immunotherapy.
    Park W; Heo YJ; Han DK
    Biomater Res; 2018; 22():24. PubMed ID: 30275967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors.
    Qian X; Shi Z; Qi H; Zhao M; Huang K; Han D; Zhou J; Liu C; Liu Y; Lu Y; Yuan X; Zhao J; Kang C
    Theranostics; 2019; 9(25):7616-7627. PubMed ID: 31695790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides that immunoactivate the tumor microenvironment.
    Furukawa N; Popel AS
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188486. PubMed ID: 33276025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.